Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.

BMJ open - 21 Aug 2017

Liu Qing-Feng, Zhang Zhi-Fei, Hou Guang-Jie, Yang Guang-Yu, He Yi

Abstract excerpt

OBJECTIVES: To evaluate the prognostic relevance of four functional single nucleotide polymorphisms (SNPs) in CD133 (rs2240688A>C, rs10022537T>A, rs7686732C>G, and rs3130C>T) on overall survival (OS) of non-small cell lung cancer (NSCLC) patients. DESIGN: Retrospective cohort study. SETTING: Department of General Surgery, in a general hospital, Henan Province, China. PARTICIPANTS: NSCLC patients aged ≥18 years,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Kaplan-Meier Estimate

Share to Lung Neoplasms

Share to Proportional Hazards Models

Share to Stem Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 28827262
DOI: 10.1136/bmjopen-2017-016913
PMCID: PMC5724226

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.PMID 28827262Read ↗

Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.Semantic proximity Read ↗

A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.Semantic proximity Read ↗

A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.Semantic proximity Read ↗

The Contribution of CD133 Gene Polymorphisms to Cancer Risk: Integrating Case-Control Evidence With Meta-Analysis.Semantic proximity Read ↗

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.Semantic proximity Read ↗

Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.Semantic proximity Read ↗

Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinomaSemantic proximity Read ↗

CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancerSemantic proximity Read ↗

Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.Semantic proximity Read ↗

Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer.Semantic proximity Read ↗

New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulationSemantic proximity Read ↗

Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.